Effect of Speed,Agility and Quickness Training on Technical Skills in Football Players

April 15, 2022 updated by: Riphah International University

Effect of Speed, Agility and Quickness Training on Technical Skills in Football Players

The study is designed to determine the effectiveness of Speed, Agility and Quickness training on technical skills in football players

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Football is a fast-paced, dynamic sport that requires expert movements. The goal of the game is to outscore your opponent in terms of goals scored. Players must perform a variety of expert movements, both with and without the ball, to achieve this goal. 'The learned ability to bring about predetermined results with utmost assurance, frequently with the least investment of time or energy or both,' according to an initial definition of talent. 'The constant output of goal-oriented movements, which are taught and unique to the job,' according to a more modern definition of competence. It is critical for players to have the fundamental motor abilities, such as running, agility, and acceleration, in order to learn and execute soccer skills effectively. Fundamental motor skills are seen as essential precursors or related factors to technical skills and therefore excellence in soccer.Furthermore, through a variety of soccer-specific activities, the SAQ training system consolidates speed, agility, and quickness. All exercises are carried out with appropriate biomechanical movement structures, resulting in significant energy and time savings. Aside from major abilities, power performance necessitates optimal joint mobility, dynamic balance, an appropriate locomotors system, and energy generation, among other things.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
50

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • ICT
      • Islamabad, ICT, Pakistan, 44000
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male players
  • Age group of 18 years to 25 years.
  • The study includes players, who are playing form 6 months to 1 year.

Exclusion Criteria:

  • Players with any disability
  • Injured players
  • Players with psychological issues
  • Players who are on any sort of medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Interventional Group
  1. Warm up and cool down (10 minutes before physical activity)

  2. Players will be given the SAQ training which includes

    • High Knees with Mini Hurdles.
    • 30 Yard Sprint.
    • Agility Ring Hops.
    • Ladder 2 in 2 out.
    • Depth Jumps.
    • Overhead Ball Drop Reaction Drill
Other: SAQ training
interventions listed above were applied on the players which will improve running mechanics and impove speed power and agility in football players
Other Names:
  • High knee with mini hurdles
  • depth jumps
  • 30 yard sprint
  • Agility rings hops
  • Overhead ball drop
No Intervention: Control Group

Players in this group did not undergo any interventional Programme rather than their daily routine work which includes:

  • Dumbbell squat
  • Dumbbell bicep arm curl
  • Burpee pull up
  • Medicine ball pushups
  • Sprints
  • HIIT on treadmill

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Shuttle Run test
Time Frame: 6 weeks
Agility Shuttle Run is a test of agility, in which the participant runs back and forth between two parallel lines as fast as possible, picking up blocks of wood, for a total of 120 ft. A shuttle run time below four seconds is generally considered great, with the best players closer to the 3.8-second range, the total time is 4 seconds.
6 weeks
12 min run test
Time Frame: 6 weeks
Place markers at set intervals around the track to aid in measuring the completed distance. Participants run for 12 minutes, and the total distance covered is recorded.
6 weeks
Speed
Time Frame: 6 weeks
Set out a series of markers in a straight line at 0, 10, 20 and 30m. The player taking the test stands at the start, and the person timing stands on the 10m mark. On command, the player sprints through the 10m mark and the timer records the time they pass the marker. Repeat for 10m, and then do twice for 20m and 30m.
6 weeks
Vertical jump
Time Frame: 6 weeks
The simplest method to measure an athlete's vertical jump is to get the athlete to reach up against a flat wall, with a flat surface under his/her feet and mark off the highest point he/she can reach flat-footed
6 weeks
Mcdonald Soccer skill test
Time Frame: 6 weeks
A soccer ball is placed on a line, marked 9 feet from the wall. On the signal, "Go," the player kicks the ball against the wall as many times as possible in 30 seconds. The test score is the highest total of any three trials.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 29, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 31, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 1, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 20, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 20, 2022

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 2, 2022

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 18, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 15, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/01023/Sajjad Ali

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings